IOVA Iovance Biotherapeutics Options Ahead of Earnings

Analyzing the options chain of IOVA Iovance Biotherapeutics prior to the earnings report this week,
I would consider purchasing the 7.5usd strike price Puts with
an expiration date of 2023-6-16,
for a premium of approximately $0.70
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.

Looking forward to read your opinion about it.

Trade closed: target reached:

IOVA trading at $7.97 after earnings and calls at $1.10, from $0.70 when I wrote this article. About 60% gain!

Trade active:

Iovance Biotherapeutics has made an announcement regarding the acceptance of the Biologics License Application by the U.S. Food and Drug Administration for Lifileucel, a treatment intended for advanced melanoma.